Compounding Pharmacy · Kirkland, WA · 503A

Aequita Pharmacy Review

Aequita Pharmacy is a 503A compounding pharmacy in Kirkland, Washington that compounded semaglutide and tirzepatide injectables, including for telehealth brand Mochi Health. Washington's Department of Health issued a Limited Stop Service order against the pharmacy after an inspection reportedly found illegally imported bulk GLP-1 ingredient, so patients were moved to other pharmacies.

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

503A
Location: Kirkland, WA
States licensed: 0
3.0
☆☆☆1.5/5

Editorial score · methodology

Telehealth Providers Sourcing From This Pharmacy

These telehealth brands are reported to fulfill some or all compounded GLP-1 prescriptions through Aequita Pharmacy. Sourcing arrangements can change over time.

7.7/ 10

Mochi Health

Best for: budget-conscious shoppers

★★★3.9/5

Editorial score · methodology

CompoundedSemaglutideTirzepatide
Get StartedRead full Mochi Health review →

Top-Rated GLP-1 Partners

Not sourced from Aequita Pharmacy — these are our highest-scored vetted telehealth partners for compounded GLP-1s, if you'd rather start with a provider we've walked through end to end.

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

No insurance needed · HSA/FSA eligible · vetted by our editors

6.4

Direct Meds

Listed for disclosure only — see its FDA warning and BBB complaints first

Starting price: $249/mo

Get started →Read review Direct Meds
7.6

Maximus

Men seeking compounded GLP-1 alongside testosterone optimization

Starting price: $199.99/mo

Get started →Read review Maximus
8.0

Sesame Care

Brand-name GLP-1s at cash prices, no compounding

Starting price: $25/mo

Get started →Read review Sesame Care
6.9

Try Ageless

Lowest-tier compounded GLP-1 in injection, troche and sublingual forms

Starting price: $119/mo

Get started →Read review Try Ageless

Certifications & Compliance

All sterile compounding pharmacies in the United States are required to follow United States Pharmacopeia General Chapter <797> sterile compounding standards[4], with finished preparations evaluated against USP <71> sterility testing[5] and USP <85> bacterial endotoxin testing[6] as appropriate for the product type.

We have not verified any third-party accreditations for this pharmacy beyond its state pharmacy license.

Drugs Produced

Compounding pharmacies' ability to produce semaglutide or tirzepatide depends on the FDA Drug Shortage List status for each reference product; compounding eligibility can change when a drug moves on or off the shortage list[7].

Semaglutide
Compounded semaglutide produced
Tirzepatide
Compounded tirzepatide produced

States Licensed

Aequita Pharmacy has not published a state-by-state licensure list. Verify licensure for your state directly with your state board of pharmacy before filling a prescription here.

Regulatory Actions

2025-03
Washington State Dept. of Health Pharmacy Quality Assurance Commission issued a Limited Stop Service on the pharmacy's license; a state inspection reportedly found illegally imported GLP-1 bulk API. Cannot compound or dispense in Washington until resolved.

Weight Loss Rankings Score Breakdown

Accreditation & Compliance6/10
Regulatory Standing5/10
State Coverage0/10
GLP-1 Production10/10
Track Record5/10

Scores are independently researched. See our methodology for details.

High confidence · Last verified 2026-07-16 via research · How we verify provider data

Frequently Asked Questions

Aequita Pharmacy is a 503A compounding pharmacy based in Kirkland, WA. It operates under state board of pharmacy licensure. Note: our records show 1 documented regulatory action(s) — see the Regulatory Actions section below.
Aequita Pharmacy is headquartered in Kirkland, WA. The pharmacy is licensed to ship to 0 US states.
Aequita Pharmacy produces compounded semaglutide and compounded tirzepatide in addition to other compounded preparations. As a 503A pharmacy, it dispenses compounded medications in response to individual patient prescriptions under state board of pharmacy oversight.
503A pharmacies prepare compounded medications for individual patients in response to specific prescriptions and are regulated primarily by state boards of pharmacy under USP <797> sterile compounding standards. 503B outsourcing facilities register directly with the FDA, follow current Good Manufacturing Practices (cGMP), and can produce compounded medications in larger batches without patient-specific prescriptions. 503B facilities are subject to FDA inspection.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Sources & methodology — as of August 2026
  1. 1.FDA — Compounding and the 503A Pharmacy FrameworkU.S. Food & Drug Administration.
  2. 2.FDA — 503B Outsourcing Facility Registration and RequirementsU.S. Food & Drug Administration.
  3. 3.PCAB — Pharmacy Compounding Accreditation Board StandardsAccreditation Commission for Health Care (ACHC) / PCAB.
  4. 4.USP General Chapter <797> — Pharmaceutical Compounding: Sterile PreparationsUnited States Pharmacopeia.
  5. 5.USP General Chapter <71> — Sterility TestsUnited States Pharmacopeia.
  6. 6.USP General Chapter <85> — Bacterial Endotoxins TestUnited States Pharmacopeia.
  7. 7.FDA — Drug Shortages Database (current shortage listings)U.S. Food & Drug Administration.